13F HOLDINGS REPORT
Checkpoint Capital L.P.
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0001977548-24-000008
Total Value
$201.6M
Positions
16
Other Managers
0
Confidential Omitted
No
Holdings (16)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ARGENX SE | ARGX | 92,500 | $50.1M | 24.88% |
| 2 | RHYTHM PHARMACEUTICALS INC | RYTM | 663,381 | $34.8M | 17.24% |
| 3 | PHATHOM PHARMACEUTICALS INC | PHAT | 1,504,307 | $27.2M | 13.49% |
| 4 | CYTOKINETICS INC | CYTK | 466,813 | $24.6M | 12.23% |
| 5 | AXSOME THERAPEUTICS INC | AXSM | 209,632 | $18.8M | 9.35% |
| 6 | AVADEL PHARMACEUTICALS PLC | G29687103 | 1,100,000 | $14.4M | 7.16% |
| 7 | PROTAGONIST THERAPEUTICS INC | PTGX | 240,000 | $10.8M | 5.36% |
| 8 | PLIANT THERAPEUTICS INC | PLRX | 380,000 | $4.3M | 2.11% |
| 9 | TSCAN THERAPEUTICS INC | TCRX | 825,341 | $4.1M | 2.04% |
| 10 | ATYR PHARMA INC | ATYR | 1,736,477 | $3.1M | 1.52% |
| 11 | SOLENO THERAPEUTICS INC | SLNO | 57,983 | $2.9M | 1.45% |
| 12 | CIDARA THERAPEUTICS INC | 171757206 | 182,426 | $2.0M | 0.97% |
| 13 | STOKE THERAPEUTICS INC | STOK | 157,514 | $1.9M | 0.96% |
| 14 | DISC MEDICINE INC | IRON | 25,543 | $1.3M | 0.62% |
| 15 | TREVI THERAPEUTICS INC | TRVI | 250,000 | $835,000 | 0.41% |
| 16 | ALLAKOS INC | 01671P100 | 649,957 | $424,552 | 0.21% |